Sen-Jam Pharmaceutical TAKES THE STAGE AT EUROPEAN BIOPHARMA OBESITY INNOVATION FORUM

Category 1 (1)

Public Health Impact | Science Beyond the Solutions | The Sen-Jam Perspective

Sachs Biopharma Event June

We could not be more proud of Jackie—our brilliant Female Founder and the only woman on today’s stage—and of our team’s progress in advancing science that can truly make a difference. It’s moments like these that underscore Sen-Jam’s bold and growing role in advancing breakthrough science to improve global health outcomes.

Thank you for your continued belief in our mission. The future is bright, and we’re just getting started.

June 11, 2025 – This past week, our executive team has been on the ground in Europe, connecting with the scientific and biopharma community—and helping to shape the conversation around the future of metabolic health.

Today, we had the honor of attending the Sachs European Biopharma Obesity Innovation Forum in Leipzig, Germany—a gathering of some of the brightest minds working to combat one of the world’s most urgent health crises.

The World Health Organization projects that by 2035, over half of the global population will be overweight or obese. The urgency for innovation has never been greater.

At today’s forum, our Co-Founder and Chief Clinical Officer, Jackie Iversen, RPh, MS, took center stage—not only delivering a powerful 20-minute presentation on Sen-Jam’s emerging role in addressing metabolic disorders, but also joining a live panel alongside Big Pharma leaders to discuss advancements in CardioRenal, Metabolic, and Obesity platforms.

In the video below, you’ll see a short clip of Jackie’s perspective on how biomarkers can help drive solutions across multiple therapeutic areas—an approach core to our work at Sen-Jam.

Recent Posts
Sachs Biopharma Event June

Sen-Jam Pharmaceutical Takes the Stage European Biopharma Obesity Innovation For...

Sen-Jam Speaks at the Sachs European Biopharma Obesity Innovation Forum in Leipzig, Germany—a gathering of some of the brightest minds working to combat one of the world’s most urgent health crises.
Mask Group (17)

Sen-Jam Pharmaceutical Announces Planned AI Initiative for Molecule Repurposing

HUNTINGTON, N.Y., Jan. 10, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical (“Sen-Jam”), a pioneer in innovative inflammatory care, today announced a planned new initiative for use of leading-edge AI tools…
Group 1000001206

Sen-Jam Pharmaceutical Joins Forces with The Global Passion Project for Transfor...

HUNTINGTON, N.Y., April 1, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical is proud to sponsor and participate in The Global Passion Project’s upcoming Healthcare Investor Summit, taking place…

Media Inquiry